Related Experiment Video
Updated: Jan 6, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Clinical Characteristics and Risk Factors of Coronary Artery Disease in Patients with Hypertension and Persistent
Jia-Qi Bai1, Yi-Ning Liu2, Rui-Zhe Li3
1Department of Cardiology, The Sixth Medical Center of Chinese People's Liberation Army (PLA) General Hospital, Beijing 100037, China.
Insights
Coronary artery disease (CAD) affects two-thirds of hospitalized patients with hypertension and atrial fibrillation (HT-AF). Age is the only independent risk factor for CAD in this group, despite high stroke risk and low anticoagulant use.
Area of Science:
- Cardiology
- Internal Medicine
- Clinical Research
Background:
- Hypertension (HT) and atrial fibrillation (AF) frequently coexist, increasing cardiovascular risk.
- Coronary artery disease (CAD) is a leading cause of mortality, and its overlap with HT and AF presents management complexities.
Purpose of the Study:
- To investigate the clinical characteristics and risk factors for CAD in patients with both HT and persistent AF (HT-AF).
Main Methods:
- Retrospective cross-sectional study of 384 hospitalized HT-AF patients.
- CAD diagnosis confirmed via coronary angiography or CT angiography.
- Multivariate logistic regression used to identify independent risk factors for CAD.
Main Results:
- CAD prevalence was 66.41% in the HT-AF cohort.
- Heart failure was more common in patients with CAD (44.7%) compared to those without (25.6%).
- Age was the only independent risk factor for CAD (adjusted OR: 1.047).
- 54.7% of patients had a high stroke risk (CHA2DS2-VASc score ≥4).
- Oral anticoagulant use was low (8.6% in CAD group vs. 4.7% in non-CAD group).
Conclusions:
- CAD is highly prevalent in hospitalized HT-AF patients.
- Age is the sole identified independent risk factor for CAD in this population.
- Low oral anticoagulant utilization persists despite high stroke risk in HT-AF patients.
Abstract:
BACKGROUND AND OBJECTIVE: Hypertension (HT) and atrial fibrillation (AF) are highly prevalent cardiovascular conditions that frequently coexist. Coronary artery disease (CAD) is a major global cause of mortality. The co-occurrence of HT, AF, and CAD presents significant management challenges. This study aims to explore the clinical characteristics and risk factors associated with CAD in patients with HT and persistent AF (HT-AF). METHODS: In this retrospective cross-sectional study, data were collected from 384 hospitalized HT-AF patients at the People's Liberation Army General Hospital between January 2010 and December 2019. CAD diagnosis was confirmed by coronary angiography or computed tomography angiography. Clinical characteristics and comorbidities were compared between patients with and without CAD. Multivariate logistic regression analyses were performed to identify independent risk factors associated with CAD development. RESULTS: The prevalence of CAD among HT-AF patients was 66.41% (255/384). Cardiovascular complications, particularly heart failure (44.7% vs 25.6%, P < 0.05), were significantly more prevalent in the CAD group than in the non-CAD group. Only age was identified as an independent risk factor for CAD (adjusted OR: 1.047; 95% CI: 1.022-1.073; P = 0.000). Of all HT-AF patients, 54.7% had a CHA2DS2-VASc score of ≥4, indicating high stroke risk. There was a slightly higher anticoagulant usage rate in the CAD group than those without CAD (8.6% vs 4.7%, P = 0.157), and the overall anticoagulant usage remained low. CONCLUSION: There is a high prevalence of CAD among hospitalized HT-AF patients, among whom age is the sole independent risk factor for CAD. Despite a high stroke risk, the utilization of oral anticoagulants is alarmingly low.
More Related Videos
Related Concept Videos
Coronary Artery Disease I: Introduction
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease IV: Preventive Measures
Hypertension III: Clinical Manifestations and Diagnostic Studies
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Hypertension II: Pathophysiology

